Table 1.
Design of simulation 1 for evaluation
Gene ID | Treatment Group | Control Group |
1 | Exon 5~N (0, 1) | All exons ~N (2.5,1), correlated |
Exon 6~N (0, 1) | ||
Others ~N (2.5, 1), correlated | ||
2 | Exon 5~N (0, 1) | All exons ~N (1.5,1), correlated |
Exon 6~N (0, 1) | ||
Others ~N (1.5, 1), correlated | ||
3 | Exon 5~N (2.5, 1) | Exon 5~N (0, 1) |
Exon 6~N (0, 1) | Exon 6~N (2.5, 1) | |
Others ~N (2.5, 1), correlated | Others ~N (2.5, 1), correlated | |
4 | Exon 5~N (1.5, 1) | Exon 5~N (0, 1) |
Exon 6~N (0, 1) | Exon 6~N (1.5, 1) | |
Others ~N (1.5, 1), correlated | Others ~N (1.5, 1), correlated |
Exon 5 and Exon 6 are simulated as cassette exons in alternatively spliced gene 1 and 2, while they are defined as mutually exclusive exons in alternatively spliced gene 3 and 4.